MARY KAY CC CREAM
Google image searchProduct monograph
Active ingredients
octinoxate, 6.5 %/W/W
homosalate, 5.0 %/W/W
oxybenzone, 1.2 %/W/W
DIN: 02414430
Dosage form(s): CREAM
Route(s) of administration: TOPICAL
Schedule: OTC
Company: MARY KAY COSMETICS LTD
Date: 16-FEB-2014
ATC:
- D02 — EMOLLIENTS AND PROTECTIVES (ATC, ATC/DDD, )
- D02B — PROTECTIVES AGAINST UV-RADIATION (ATC, ATC/DDD)
- D02BA — Protectives against UV-radiation for topical use (ATC, ATC/DDD)
- D02BA30 — COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION (ATC/DDD)
Pharmaceutical standard: MFR
